Biodesix Historical Cash Flow

BDSX Stock  USD 0.83  0.02  2.35%   
Analysis of Biodesix cash flow over time is an excellent tool to project Biodesix future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 15.6 M or Stock Based Compensation of 4.2 M as it is a great indicator of Biodesix ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Biodesix latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biodesix is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

About Biodesix Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Biodesix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Biodesix's non-liquid assets can be easily converted into cash.

Biodesix Cash Flow Chart

At this time, Biodesix's Change To Inventory is fairly stable compared to the past year. Net Borrowings is likely to rise to about 15.6 M in 2025, whereas Investments are likely to drop (3.6 M) in 2025.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Biodesix to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Biodesix operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.
Most accounts from Biodesix's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Biodesix current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.At this time, Biodesix's Change To Inventory is fairly stable compared to the past year. Net Borrowings is likely to rise to about 15.6 M in 2025, whereas Investments are likely to drop (3.6 M) in 2025.
 2022 2023 2024 2025 (projected)
Other Non Cash Items13.0M7.1M3.9M7.3M
Depreciation5.8M5.5M5.5M4.3M

Biodesix cash flow statement Correlations

-0.03-0.94-0.630.09-0.170.160.550.11-0.10.060.870.95-0.41-0.25-0.370.1-0.970.07
-0.030.23-0.21-0.540.54-0.28-0.54-0.64-0.13-0.990.270.07-0.540.57-0.32-0.540.16-0.73
-0.940.230.54-0.030.13-0.27-0.51-0.070.25-0.26-0.76-0.930.430.150.47-0.090.93-0.22
-0.63-0.210.540.0-0.22-0.32-0.480.240.410.22-0.88-0.50.39-0.080.060.380.560.33
0.09-0.54-0.030.0-0.9-0.380.810.930.220.54-0.05-0.170.86-0.880.80.82-0.270.69
-0.170.540.13-0.22-0.90.55-0.7-0.95-0.29-0.570.120.02-0.760.88-0.6-0.980.35-0.82
0.16-0.28-0.27-0.32-0.380.550.0-0.370.040.230.210.22-0.390.21-0.3-0.59-0.07-0.4
0.55-0.54-0.51-0.480.81-0.70.00.710.070.560.440.290.45-0.780.520.56-0.670.5
0.11-0.64-0.070.240.93-0.95-0.370.710.370.64-0.2-0.090.83-0.940.650.92-0.280.77
-0.1-0.130.250.410.22-0.290.040.070.370.15-0.24-0.140.36-0.560.320.310.05-0.08
0.06-0.99-0.260.220.54-0.570.230.560.640.15-0.25-0.040.53-0.580.310.58-0.20.75
0.870.27-0.76-0.88-0.050.120.210.44-0.2-0.24-0.250.81-0.530.02-0.31-0.22-0.82-0.24
0.950.07-0.93-0.5-0.170.020.220.29-0.09-0.14-0.040.81-0.61-0.02-0.63-0.05-0.89-0.03
-0.41-0.540.430.390.86-0.76-0.390.450.830.360.53-0.53-0.61-0.740.890.740.230.62
-0.250.570.15-0.08-0.880.880.21-0.78-0.94-0.56-0.580.02-0.02-0.74-0.66-0.820.39-0.57
-0.37-0.320.470.060.8-0.6-0.30.520.650.320.31-0.31-0.630.89-0.660.50.230.31
0.1-0.54-0.090.380.82-0.98-0.590.560.920.310.58-0.22-0.050.74-0.820.5-0.290.86
-0.970.160.930.56-0.270.35-0.07-0.67-0.280.05-0.2-0.82-0.890.230.390.23-0.29-0.26
0.07-0.73-0.220.330.69-0.82-0.40.50.77-0.080.75-0.24-0.030.62-0.570.310.86-0.26
Click cells to compare fundamentals

Biodesix Account Relationship Matchups

Biodesix cash flow statement Accounts

202020212022202320242025 (projected)
Change To Inventory(11.7M)7.4M906K166K22K23.1K
Investments(2.9M)(2.5M)(3.5M)(22.0M)(3.4M)(3.6M)
Change In Cash56.8M(29.5M)10.4M(16.8M)(39K)(37.1K)
Net Borrowings13.0M16.0M(15.5M)16.5M14.8M15.6M
Stock Based Compensation3.7M4.9M6.0M5.4M6.6M4.2M
Free Cash Flow(23.5M)(30.8M)(48.5M)(45.9M)(51.9M)(54.5M)
Change In Working Capital(4.8M)4.6M(4.3M)11.3M(21.7M)(20.6M)
Begin Period Cash Flow5.5M62.3M32.8M43.2M26.4M28.5M
Total Cashflows From Investing Activities(1.9M)(2.9M)(2.5M)(3.5M)(3.2M)(3.3M)
Other Cashflows From Financing Activities(6.9M)30.0M(17.2M)(8.9M)(3.5M)(3.3M)
Depreciation2.9M3.2M5.8M5.5M5.5M4.3M
Other Non Cash Items6.6M4.3M13.0M7.1M3.9M7.3M
Capital Expenditures2.2M2.5M3.5M23.1M3.2M5.7M
Total Cash From Operating Activities(21.4M)(28.2M)(45.0M)(22.9M)(48.6M)(46.2M)
Change To Account Receivables(10.3M)11.5M(1.5M)(4.7M)(1.8M)(1.9M)
Change To Operating Activities17K(8.4M)2.2M(857K)(985.6K)(1.0M)
Issuance Of Capital Stock72M16.7M59.5M56.9M55.6M43.9M
Net Income(31.4M)(43.2M)(65.4M)(52.1M)(42.9M)(45.1M)
Total Cash From Financing Activities81.1M1.3M58.9M29.1M52.1M41.6M
End Period Cash Flow62.3M32.8M43.2M26.4M26.3M31.8M
Change To Netincome7.4M7.3M7.2M19.0M21.8M22.9M
Change To Liabilities2.0M13.9M(9.1M)(2.0M)(1.8M)(1.7M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.